Genevieve M. Boland
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers 46
- CAR-T cell therapy research 29
- Cutaneous Melanoma Detection and Management 21
- Immunology top 2%
- Immunotherapy and Immune Responses 27
- Genetics top 1%
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 21
- Molecular Biology top 5%
- Melanoma and MAPK Pathways 25
- vaccines and immunoinformatics approaches 10
- Single-cell and spatial transcriptomics 9
- Co-authors
- Rocky S. TuanRichard TuliDavid J. HallDennie T. FrederickGéraldine PerkinsRonald J. WeigelKeith T. FlahertyLeslie M. Fischer
- Cited by
- OncologyImmunologyGenetics
- Journals
- Journal of Clinical Oncology (19 papers)Annals of Surgical Oncology (11 papers)Cancer Research (7 papers)
- Partner nations
- United StatesChinaAustralia
In The Last Decade
Genevieve M. Boland
105 papers receiving 5.5k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Oncology 2.3k
- Immunology 1.4k
- Genetics 676
- Cancer Research 744
- Molecular Biology 2.1k
Countries citing papers authored by Genevieve M. Boland
This map shows the geographic impact of Genevieve M. Boland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Genevieve M. Boland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Genevieve M. Boland more than expected).
Fields of papers citing papers by Genevieve M. Boland
This network shows the impact of papers produced by Genevieve M. Boland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Genevieve M. Boland. The network helps show where Genevieve M. Boland may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Genevieve M. Boland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 10 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 9 | |
| 8 | 2023 | 13 | |
| 9 | 2023 | 7 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 0 | |
| 12 | 2023 | 0 | |
| 13 | 2023 | 0 | |
| 14 | 2021 | 8 | |
| 15 | 2020 | 17 | |
| 16 | 2020 | 178 | |
| 17 | 2018 | 93 | |
| 18 | 2017 | 53 | |
| 19 | 2017 | 240 | |
| 20 | 2012 | 87 |
About Genevieve M. Boland
Genevieve M. Boland is a scholar working on Oncology, Immunology and Cancer Research, having authored 121 papers that have together received 5.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (46 papers), CAR-T cell therapy research (29 papers), Immunotherapy and Immune Responses (27 papers), Melanoma and MAPK Pathways (25 papers), Cancer Genomics and Diagnostics (21 papers), Cutaneous Melanoma Detection and Management (21 papers), vaccines and immunoinformatics approaches (10 papers) and Single-cell and spatial transcriptomics (9 papers). The work is most often cited by research in Oncology (2.3k citations), Immunology (1.4k citations) and Genetics (676 citations). Genevieve M. Boland has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Rocky S. Tuan, Richard Tuli, David J. Hall, Dennie T. Frederick, Géraldine Perkins, Ronald J. Weigel, Keith T. Flaherty, Leslie M. Fischer, Ryan J. Sullivan and Gordon J. Freeman. Their work appears in journals such as Journal of Clinical Oncology, Annals of Surgical Oncology, Cancer Research, Clinical Cancer Research and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.